Search results
Type 2 narcolepsy: Symptoms, causes, treatments, and more
Medical News Today· 7 days agoNarcolepsy is a long-term disorder of the brain and nervous system that interferes with a person’s...
TD Cowen starts Alkermes stock coverage with Buy By Investing.com
Investing.com· 1 day agoThe firm's coverage begins with a positive outlook on the biopharmaceutical company, particularly...
Chesterfield firm spent 5 years developing its narcolepsy drug. 'The real work begins now.'
St. Louis Post-Dispatch· 4 days agoFive years ago, struggling in the wake of a disappointing drug rollout, a small Chesterfield pharmaceutical firm made a bold bet. Avadel Pharmaceuticals trimmed tens of millions in expenses ...
Adderall shortage could affect over 40,000 Americans, CDC warns
United Press International via Yahoo News· 3 days agoThe U.S. Centers for Disease Control and Prevention is warning Americans about a possible shortage...
Urgent Need for Policies to Lower Americas' Insomnia Burden
Medscape· 16 hours agoA new analysis highlights the high burden of insomnia across the Americas, with about 17% of adults...
Citi maintains buy on Axsome, price target steady at $125 By Investing.com
Investing.com· 6 days agoOn Wednesday, Citi reaffirmed its Buy rating on Axsome Therapeutics (NASDAQ:AXSM) with a consistent...
Can Adderall Help With My Anxiety?
MediaFeed via AOL· 3 days agoAdderall and anxiety: Two things that don’t mix too terribly well. Adderall is a medication used to treat attention-deficit/hyperactivity disorder...
Free course shines light on sleep health | Newswise
Newswise· 5 days agoThe average person spends one-third of their life sleeping. In fact, said Ronald Chervin, M.D., a professor of neurology and director of the Sleep Disorders Centers at Michigan Medicine, “So ...
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Stock Position Lowered by BVF Inc. IL
ETF DAILY NEWS· 6 days agoBVF Inc. IL cut its holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 7.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned ...
Avadel Pharmaceuticals (NASDAQ:AVDL) Receives New Coverage from Analysts at Rodman & Renshaw
ETF DAILY NEWS· 6 days agoRodman & Renshaw assumed coverage on shares of Avadel Pharmaceuticals (NASDAQ:AVDL – Free Report) in a research note issued to investors on Wednesday morning, Marketbeat reports. The brokerage ...
